NCT07614997招募中不适用
Evaluation of the Effectiveness and Safety of the Ulthera® System for Treating Skin Laxity in the Lower Face, Submentum and Neck
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 218
- 试验地点
- 7
研究概览
简要总结
The purpose of this study is to demonstrate superiority of treatment with the Ulthera System compared to untreated control for the improvement of skin laxity of the lower face, submental area and neck and to demonstrate the safety of treatment with the Ulthera System for the improvement of skin laxity of the lower face, submental area and neck.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 35 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Mild to moderate lower face, submental and/or neck laxity, that is amenable to improvement with non-invasive intervention and not severe enough for surgical intervention.
- •Willing to abstain from all other aesthetic treatments on ANY part of the face, submentum or neck, including but not limited to injectable fillers, implants, neurotoxin, skin peels, laser treatments, surgical treatments, etc. for the clinical investigation's duration.
- •Willing and able to refrain from chronic use of aspirin, ibuprofen, naproxen, or other nonsteroidal anti-inflammatory drugs (NSAIDs) for 10 to 14 days post-treatment.
- •Has an adequate understanding of the Chinese language.
- •Willing and able to comply with protocol requirements.
排除标准
- •Scarring in area(s) to be treated.
- •Any active implants.
- •Any metallic implants in area(s) to be treated.
- •Any open wounds or lesions, including active herpes simplex, in the area(s) to be treated.
- •Presence of an active systemic or local skin disease, including active, cystic, or severe inflammatory acne in the area(s) to be treated.
- •History of keloid formation or hypertrophic scarring.
- •History of the following cosmetic treatments in area(s) to be treated:
- •Skin-tightening procedure,
- •Injectable crosslinked hyaluronic acid (HA)/collagen temporary dermal fillers of the lower face, submentum or neck within the past 12 months.
- •Injectable non-crosslinked HA dermal fillers of the lower face, submentum or neck within the past 6 months.
- •Injectable semi-permanent/permanent facial fillers
- •Neurotoxin treatment of the lower face, submentum or neck within the past 6 months.
- •Liposuction of the lower face, submentum or neck within the last 12 months.
- •Fat grafting of the lower face, submentum or neck within the last 12 months.
- •Deoxycholic acid within the last 12 months; and/or
- •Chemical peeling or dermabrasion treatments within the past 12 months.
- •Cryolipolysis
- •Had prior surgery in the lower-facial area and/or neck/submentum or has a permanent implant or graft in the lower-facial area that could interfere with effectiveness assessments.
- •Has undergone oral surgery in the past 30 days.
- •Participants who have used isotretinoin or other retinoid medications within 6 months prior to enrollment or have applied topical retinoid-containing medications on the face or neck area within 2 weeks prior to enrollment or planning such treatments during the study period.
- •Marked facial asymmetry, deep dermal scarring, or thick sebaceous skin in the full face.
- •Severe solar elastosis.
- •Facial nerve palsy or history of facial nerve palsy.
- •Tattoos in the area(s) to be treated (excluding microblading eyebrow).
- •Current smoker or history of smoking in the last 12 months.
- •Current daily user of any nicotine-containing products
- •Is a female of childbearing potential1 and not using medically effective birth control 2 or is pregnant, lactating, or planning to become pregnant during the clinical investigation.
研究组 & 干预措施
Treatment With Ulthera System
Experimental
Participants randomized to receive a single treatment with Ulthera system to lower face, submentum and neck on Day 1.
干预措施: Ulthera System (Device)
Control/Delayed treatment With Ulthera System
Other
Participants will remain untreated until Day 90 and then receive a single treatment with Ulthera system to lower face, submentum and neck.
干预措施: Ulthera System (Device)
研究者
研究点 (7)
Loading locations...
相似试验
尚未招募
2/3 期
A study to evaluate the effect of an Ayurvedic formulation containing castor oil (Eranda taila) and Haritaki powder in relieving symptoms of Sciatica (Gridhrasi).CTRI/2025/10/096199Dr Vaibhav Mohan Awatade80
进行中（未招募）
不适用
Evaluating Universal Adhesives in Cervical LesionsNCT07459374Hacettepe University30
尚未招募
不适用
An interventional trial to evaluate the effect of an Ayurveda treatment protocol in Allergic rhinitisCTRI/2025/04/085568DrPreethi Mohan41
尚未招募
4 期
supraclavicular subclavain vein v/s IJV cannulation which is safe and better in adult pateint requiring GA.CTRI/2025/11/097652MGM Medical college and Hospital Aurangabad60
尚未招募
2 期
A study to compare the effect of two ayurvedic medicines and ayurvedic lepa in the management of melasama.CTRI/2025/07/091770pt khushilal sharma govt autonomous ayurveda college and institue bhopal mp40